4,5-di(amino)-2-hydroxybenzoic acid | 90833-87-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4,5-di(amino)-2-hydroxybenzoic acid
• 英文别名: 4,5-diamino-2-hydroxy-benzoic acid；4,5-Diamino-2-hydroxy-benzoesaeure；4,5-diaminosalicylic acid；3,4-Diamino-6-hydroxy-benzoesaeure；4,5-Diamino-2-hydroxybenzoic acid
• CAS: 90833-87-7
• 化学式: C₇H₈N₂O₃
• 分子量: 168.152
• InChiKey: REORQLPSELYKMX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  110
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4,5-di(amino)-2-hydroxybenzoic acid 、 N-亚磺酰苯胺 在 吡啶 作用下， 生成 6-hydroxy-benzo[1,2,5]thiadiazole-5-carboxylic acid
  参考文献：
  名称：

  Pesin et al., Zhurnal Obshchei Khimii, 1957, vol. 27, p. 1570,1572; engl. Ausg. S. 1643, 1645

  摘要：

  DOI：
• 作为产物：
  描述：

  4-苯酰胺-2-羟基苯甲酸 在 sodium hydroxide 、 sodium dithionite 、 硫酸 、 硝酸 作用下， 生成 4,5-di(amino)-2-hydroxybenzoic acid
  参考文献：
  名称：

  van der Stelt et al., Arzneimittel-Forschung/Drug Research, 1954, vol. 4, p. 544,546

  摘要：

  DOI：

文献信息

• HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
  申请人：McCall John M.

  公开号：US20140128392A1

  公开（公告）日：2014-05-08

  Disclosed herein are new heterocyclic compounds of Formula IIa: and compositions thereof, and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

  本文披露了新的Formula IIa的杂环化合物及其组合物，以及它们作为治疗疾病的药物的应用。还提供了在人类或动物主体中抑制PAS激酶（PASK）活性的方法，用于治疗糖尿病等疾病。
• 3-deoxyglucosone and skin
  申请人：——

  公开号：US20030219440A1

  公开（公告）日：2003-11-27

  The invention relates to a method of removing 3-deoxyglucosone and other alpha-dicarbonyl sugars from skin. The invention further relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin. The invention also relates to methods of treating 3-deoxyglucosone and other alpha-dicarbonyl sugars associated diseases and disorders of skin.

  该发明涉及一种从皮肤中去除3-去氧葡萄糖酮和其他α-二酮糖的方法。该发明还涉及抑制皮肤中3-去氧葡萄糖酮和其他α-二酮糖的产生和功能的方法。该发明还涉及治疗与皮肤相关的3-去氧葡萄糖酮和其他α-二酮糖相关疾病和障碍的方法。
• 4,5-Diamino-3-Halo-2-Hydroxybenzoic Acid Derivatives and Preparations Thereof
  申请人：LEE AN-RONG

  公开号：US20120101157A1

  公开（公告）日：2012-04-26

  Disclosed are 4,5-diamino-3-halo-2-hydroxybenzoic acid derivatives and manufactures thereof. The 4,5-diamino-3-halo-2-hydroxybenzoic acid derivatives are presented by formula (I): wherein R 1 group is H, CH 3 , or C 2 H 5 ; R 2 group is H, or Br; R 3 group is CH 3 , or C 3 H 7 ; and R 4 group is H, or C(═NH)—NH 2 . 4,5-diamino-3-halo-2-hydroxybenzoic acid derivatives provided here were non-toxic to MDCK cells, particularly compounds 6 a , 6 b , 6 c , 6 e , 6 f , 7 a , 7 b and 8 had better anti-H1N1 activity. In the future, these compounds can be used to focus on viral neuraminidases as targets to develop effective anti-influenza drugs.

  本文披露了4,5-二氨基-3-卤代-2-羟基苯甲酸衍生物及其制备方法。所述4,5-二氨基-3-卤代-2-羟基苯甲酸衍生物由下式（I）表示：其中R1基团为H、CH3或C2H5；R2基团为H或Br；R3基团为CH3或C3H7；R4基团为H或C(═NH)—NH2。本文提供的4,5-二氨基-3-卤代-2-羟基苯甲酸衍生物对MDCK细胞无毒，特别是化合物6a、6b、6c、6e、6f、7a、7b和8具有更好的抗H1N1活性。未来，这些化合物可以用于将病毒神经氨酸酶作为靶点，开发有效的抗流感药物。
• Substituted 5- and 6-quinoxalinecarboxylic acids and their tuberculostatic activity
  作者：František Roubínek、Viktor Bydžovský、Zdeněk Buděšínský

  DOI：10.1135/cccc19840285

  日期：——

  Condensation of aliphatic and aliphatic-aromatic α-diketones, and of substituted benzils with 2,3- and 3,4-diaminobenzoic acids and with 4,5-diamino-2-hydroxybenzoic acid gave 74 5- and 6-quinoxalinecarboxylic acids, with the same or different alkyls and aryls as substituents at position 2 and 3. The compounds with different substituents at positions 2 and 3 were resolved into positional isomers. Their structures were determined by means of the dipole moments. The compounds were tested for tuberculostatic activity. Some exhibited it in vitro (LI, LVII), but failed in vivo.

  脂肪族和脂肪族-芳香族α-二酮与2,3-和3,4-二氨基苯甲酸以及4,5-二氨基-2-羟基苯甲酸的缩合反应产生了74种5-和6-喹啉羧酸，位置2和3上的取代基可以是相同的或不同的烷基和芳基。在位置2和3有不同取代基的化合物被分解成位置异构体。它们的结构是通过偶极矩确定的。这些化合物被检测其抗结核活性。一些化合物在体外（LI，LVII）表现出该活性，但在体内失败。
• Fructoseamine 3 kinase and the formation of collagen and elastin
  申请人：Tobia Annette

  公开号：US20070065443A1

  公开（公告）日：2007-03-22

  The invention relates to the discovery that levels of collagen and elastin can be modulated by changing the flux through the Amadori Pathway and that copper containing compounds and complexes inhibit the enzyme fructoseamine-3-kinase.

  本发明涉及到一项发现，即通过改变Amadori途径的通量可以调节胶原蛋白和弹性蛋白的水平，并且含铜化合物和配合物可以抑制酶果糖胺-3-激酶。